{"id":"W2982150584","doi":"10.1002/cam4.2603","title":"Real‐world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non‐small cell lung cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Public Health Ontario; Institut universitaire de cardiologie et de pneumologie de Québec; AstraZeneca (Canada); Université Laval; Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Cancer Society Research Institute; University Health Network; University of Toronto; AstraZeneca Canada; AstraZeneca","keywords":"Gefitinib; Medicine; Internal medicine; Osimertinib; Lung cancer; Epidermal growth factor receptor; Oncology; Rash; Chemotherapy; Cohort; Tyrosine-kinase inhibitor; Performance status; Erlotinib; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002560036,0.0002128188,0.0003215806,0.001031093,0.0001829234,0.0007466449,0.000346631,0.0002868754,0.001043041],"category_scores_gemma":[0.007959656,0.0001351703,0.0006606045,0.001421675,0.0002730414,0.000551809,0.000639786,0.0005118313,0.0001150123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007723196,"about_ca_system_score_gemma":0.0003374628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002993879,"about_ca_topic_score_gemma":0.003698835,"domain_scores_codex":[0.9986116,0.0006179383,0.0002203587,0.000154425,0.0002687317,0.0001270637],"domain_scores_gemma":[0.9925223,0.001551315,0.004777523,0.0001876092,0.0002972585,0.000664027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001724316,0.0000398918,0.9983663,0.0000127669,0.00008372161,0.00001889524,0.00003029118,0.0002042479,0.00002627575,0.00001608995,0.00008355435,0.0009455374],"study_design_scores_gemma":[0.00001317841,0.0001506505,0.9989243,0.000005271548,0.00002073635,0.00006588427,0.000054677,0.0005940667,0.00003336538,0.00002873778,0.0001056536,0.000003520437],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988745,0.0001410784,0.00006717698,0.00002952605,0.000002448658,0.000009942624,0.0006599005,0.000001681739,0.0002136945],"genre_scores_gemma":[0.9991473,0.000042461,0.00007198193,0.0000106397,0.000002982327,0.00000977104,0.0006692588,6.080575e-7,0.00004496582],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002993879,"threshold_uncertainty_score":0.0135389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01690395679656957,"score_gpt":0.3392901433306463,"score_spread":0.3223861865340767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}